Distinct effects of Re- and S-forms of LPS on modulating platelet activation
Authors:
- J. KappelmayerJKJ. Kappelmayer
- B. NagyBNB. Nagy
- 24 January 2013
- journal article
- letter
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 11 (4) , 775-778
Abstract
No abstract availableKeywords
Funding Information
- Hungarian Scientific Research Fund (T75199)
- Magyar Tudományos Akadémia
This publication has 13 references indexed in Scilit:
- Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activationJournal of Thrombosis and Haemostasis, 2011
- Aggregation and Microparticle Production Through Toll-like Receptor 4 Activation in Platelets From Recently Menopausal WomenJournal of Cardiovascular Pharmacology, 2009
- Lipopolysaccharide Stimulates Platelet Secretion and Potentiates Platelet Aggregation via TLR4/MyD88 and the cGMP-Dependent Protein Kinase PathwayThe Journal of Immunology, 2009
- Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human plateletsBritish Journal of Haematology, 2008
- Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammationBasic Research in Cardiology, 2007
- Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndromeBlood, 2006
- R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cellsEuropean Journal of Immunology, 2006
- Platelets express functional Toll-like receptor-4Blood, 2005
- CD14 is required for MyD88-independent LPS signalingNature Immunology, 2005
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003